Q32 Bio reports Phase 2a trial results for alopecia areata drug
Go back to Q32 Bio reports Phase 2a trial results for alopecia areata drug| (NASDAQ: QTTB) | Delayed: 11.99 -0.81 (6.33%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $12.80 | 52 Week High | $ | |||
| Open | $12.60 | 52 Week Low | $ | |||
| Day High | $12.70 | P/E | N/A | |||
| Day Low | $11.50 | EPS | $ | |||
| Volume | 853,811 | |||||

